60-75% of patients are still initiated on mono therapy! The audience appears to do better than registries with most answers around 20% 🧐Olivier Sitbon #WSPH2024 WSPH Association Ryan J Tedford MD Yuichi Tamura/ 田村雄一：心臓/循環器の学際領域のひと

What a strong start to day 3 of #wsph2024! 💪🏻 👏🏻👏🏻to Ryan J Tedford MD and all on TF12 for their work on standardizing the staging of PH-LHD. A cornerstone the community needs to better understand, treat and (most importantly) study this difficult to manage disease

That’s a wrap on #WSPH2024! Thanks to WSPH Association for organizing such an informative global event for the betterment of our #PH patients. Also, big thanks to Dr Mardi Gomberg for the early career advice and getting me to my first WSPH!

Registration is OPEN for the 1st Annual Chicago Hemodynamic Forum! Join us Nov. 15th to discuss the best practices in hemodynamic assessment and interpretation across the spectrum of cardiovascular disease processes. Register here: uchicagohemodynamics.com #CardioTwitter #CME

This combined data from #TRITON & #REPAIR studies (N=148) on initial macitentan + tadalafil therapy shows; 📍#PVR reduction: -55% (no comorbidities) & -50% (1-2 comorbidities) at Week 26 📍Functional improvements observed, lesser extent in comorbid patients 📍Majority improved

Busy day in the #UChicagoCathLab yesterday: Exercise RHC ☑️ LVAD Reverse Ramp ☑️ CardioMEMS implant ☑️ Endomyocardial Biopsies ☑️ As you're applying to AHFTC fellowship, consider cath lab experience Dive into hemodynamics in the dedicated HF cath lab University of Chicago Cardiology Fellowship!

Thank you @abbottcardio for hosting another successful Heart🫀 Lab with Dr. Salerno at Uchicago!

Nice work team! Jeremiah Haines Divyanshu Mohananey 👏🏻 👏🏻

More data gathering towards #SQUAD therapy for HFpEF! Now with positive top-line results reported for #FINEARTSHF (finerenone) and #SUMMIT (tirzepatide) 1⃣ Spironolactone ➡️ nonSteroidal MRA 2⃣ Sacubitril-valsartan 3⃣ SGLT2i 4⃣ Semaglutide or SUMMIT (tirzepatide)

HF bootcamp lectures continuing today for all our fellows. CPET talk from expert, and AHFTC PD, Sara Kalantari MD! Come learn from her at HFSA #ASM2024 during the CPET HOW (and/or apply to University of Chicago Cardiology Fellowship)!

Dynamic Assessment of LV Coupling & Myocardial Reserve in Cardiogenic Shock - API & CPO after milrinone drug study improved risk stratification in SCAI Stage C CS pts and outcomes (e.g. LVAD, OHT, or death) at 1 year. Jon Grinstein MD Mark Belkin #EHJOpen academic.oup.com/ehjopen/advanc…